Pharmacokinetics and toxicity of oral (-)-(S)-bromofosfamide in lung cancer patients.

MLA

Kobylińska, K., et al. “Pharmacokinetics and Toxicity of Oral (-)-(S)-Bromofosfamide in Lung Cancer Patients.” Arzneimittel-Forschung, vol. 51, no. 7, 2001, pp. 600–03. EBSCOhost, https://doi.org/10.1055/s-0031-1300086.

APA

Kobylińska, K., Koralewski, P., Sobik, B., Gasiorek, M., & Kobylińska, M. (2001). Pharmacokinetics and toxicity of oral (-)-(S)-bromofosfamide in lung cancer patients. Arzneimittel-Forschung, 51(7), 600–603. https://doi.org/10.1055/s-0031-1300086

Chicago

Kobylińska, K, P Koralewski, B Sobik, M Gasiorek, and M Kobylińska. 2001. “Pharmacokinetics and Toxicity of Oral (-)-(S)-Bromofosfamide in Lung Cancer Patients.” Arzneimittel-Forschung 51 (7): 600–603. doi:10.1055/s-0031-1300086.